Navigation Links
Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
Date:5/14/2013

NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays

http://www.reportlinker.com/p01171709/Immunoassays-Technologies-and-Global-Markets----Focus-on-Infectious-Disease-Immunoassays.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

STUDY GOALS AND OBJECTIVES

BCC's goal in conducting this study was to determine the current status of the worldwide demand for immunoassays and to assess its growth potential over the five-year period from 2012 to 2017. We were particularly interested in the key industry applications of immunoassay technology in the U.S., Europe, Africa, the Middle East, and Asia. In addition, we were interested in the market potential for key prevailing immunoassay technology applications. Our main objective was to present a comprehensive analysis of the current immunoassay technology markets and its future direction.

REASONS FOR DOING THIS STUDY

Immunoassays represent one of the most used testing methodologies in the world today. Hence, we were interested in determining the different immunoassay applications and examining their growth potential. We also were especially interested in determining the types of technologies currently in use and their specific applications.

BCC has over the past several years examined the biological technology industry. Within this period, Immunoassay technology used in various types of medical and other diagnostics-type applications has taken diverse configurations. As a consequence, the use of this technology is changing with time. Therefore, BCC wanted to conduct a thorough and detailed analysis of immunoassay technology and project its growth potential.

CONTRIBUTIONS TO THE STUDY AND FOR WHOM We have compiled a study of current immunoassay testing procedures markets and new emerging immunoassay technology markets. We present the economic environment of the immunoassay examination industry, technological descriptions and issues, applications, market factors, and potential, and project growth trends for the period of year 2012 to 2017. We also project market values and the distribution of immunoassay testing applications by the major market segments. This study will be of interest to the medical laboratory, in vitrodiagnostics, biotechnologies, medical diagnostic products, and drug testing industries. It will also be of interest to biological detection device hardware and software developers, manufacturing companies, and distributors.SCOPE AND FORMAT The scope of this study encompasses an investigation of the markets for the following immunoassay testing categories: enzyme, fluorescence, radio-immunoassay (RIA), cardiac analysis, infectious diseases, and tumor diagnosis. BCC analyzes each immunoassay examination type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues including the latest trends are discussed. BCC analyzes the industry on a worldwide basis, both from an application and demand point of view in the major regions of the world.METHODOLOGY BCC presents an analysis of each diagnostic application type and its estimated demand in 2012. Our estimated values are based on how much buying entities can be expected to pay in un-depreciated dollars. We then analyzed the potential applications for each usage in the field of immunoassay testing, and forecast the market size for 2012 and 2017. We also analyzed the demand for immunoassay analysis by major geographical market segments. All tables and figures are calculated in 2012 constant U.S. dollars.INFORMATION SOURCES BCC analyzed data produced by U.S. government agencies, industry trade associations, and international organizations to obtain data for this study. We also spoke with manufacturers of various immunoassay technology types in the U.S., the European Union, and Japan. In addition, we compiled data from current financial and trade information sources.REPORT HIGHLIGHTS This report provides:

• An examination of the growth of immunoassay technology in clinical, food safety, and environmental areas; this report focuses on Infectious disease immunoassays

• Analysis of global market trends, with data provided for 2011 and 2012, and projections, with five-year compound annual growth rates (CAGRs), through 2017

• Discussion of government regulations and technology patents and the roles they play in development

• Analysis of new markets

• Comprehensive company profiles of major players.

TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 2

STUDY GOALS AND OBJECTIVES 2REASONS FOR DOING THIS STUDY 2CONTRIBUTIONS TO THE STUDY AND FOR WHOM 2SCOPE AND FORMAT 3METHODOLOGY 3INFORMATION SOURCES 3RELATED REPORTS 3BCC ONLINE SERVICES 3DISCLAIMER 4

CHAPTER 2 SUMMARY 6

SUMMARY TABLE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, THROUGH2017 ($ MILLIONS) 7SUMMARY FIGURE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, 2011-2017($ MILLIONS) 7

CHAPTER 3 OVERVIEW 9

IMMUNOASSAYS 9ENZYME IMMUNOASSAYS 10TABLE 1 ADVANTAGES OF ENZYME IMMUNOASSAY 10TABLE 2 LIMITATIONS OF ENZYME IMMUNOASSAY 11FLUORESCENT IMMUNOASSAYS 11TABLE 3 ADVANTAGES OF FLUORESCENT IMMUNOASSAY 11TABLE 4 LIMITATIONS OF FLUORESCENT IMMUNOASSAY 12IMMUNOASSAY TECHNOLOGIES 12DISPOSABLE MATRIX DEVICES 13Handheld Immunochromatographic Assays (HHAs) 13BTA Test Strips 13Sensitive Membrane Antigen Rapid Test (SMART) 13REAGENT TAG BIOSENSOR APPROACHES 14NO-TAG REAGENT BIOSENSOR METHODS 14RADIOISOTOPES 15TABLE 5 ADVANTAGES OF RADIOISOTOPES 15TABLE 6 LIMITATIONS OF RADIOISOTOPES 15

CHAPTER 4 GLOBAL TRENDS IMPACTING DEMAND FOR IMMUNOASSAY TESTING 18

MEDICAL AND RESEARCH LABORATORY SUPPLIES INDUSTRY TRENDS 18DEMOGRAPHIC CHANGE 18THE MAJOR U.S. COMPETITORS 19GLOBAL DEMAND TRENDS 19TABLE 7 GLOBAL MEDICAL PRODUCTS MARKET, 2012-2017 ($ BILLIONS) 19INDUSTRY TRADE OBSTACLES AND OPPORTUNITIES 20DRUG TESTING TRENDS 20

CHAPTER 5 THE GLOBAL MARKET 22

WORLD DEMAND FOR IMMUNOASSAYS 22EUROPEAN DEMAND FOR IMMUNOASSAYS 22TABLE 8 WESTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRYTHROUGH 2017 ($ MILLIONS) 22TABLE 9 EASTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,THROUGH 2017 ($ MILLIONS) 25ASIAN DEMAND FOR IMMUNOASSAYS 26TABLE 10 ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($MILLIONS) 26TABLE 11 OCEANIA DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017($ MILLIONS) 27TABLE 12 SOUTHEAST ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,THROUGH 2017 ($ MILLIONS) 28THE AMERICAS' DEMAND FOR IMMUNOASSAYS 29TABLE 13 NORTH AMERICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,THROUGH 2017 ($ MILLIONS) 29TABLE 14 CENTRAL AND SOUTH AMERICAN DEMAND FOR IMMUNOASSAYS BYCOUNTRY, THROUGH 2017 ($ MILLIONS) 30AFRICAN DEMAND FOR IMMUNOASSAYS 31TABLE 15 NORTH AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH2017 ($ MILLIONS) 31SUB-SAHARAN AFRICAN DEMAND FOR IMMUNOASSAYS 32TABLE 16 SUB-SAHARAN AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,THROUGH 2017 ($ MILLIONS) 32MIDDLE EASTERN DEMAND FOR IMMUNOASSAYS 33TABLE 17 MIDDLE EASTERN DEMAND FOR IMMUNOASSAYS BY COUNTRY,THROUGH 2017 ($ MILLIONS) 34

CHAPTER 6 INFECTIOUS DISEASE IMMUNOASSAYS 37

TABLE 18 GLOBAL DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY REGION,THROUGH 2017 ($ MILLIONS) 37EUROPEAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 38TABLE 19 WESTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASEIMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 38TABLE 20 EASTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASEIMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 39ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 40TABLE 21 ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY COUNTRY,THROUGH 2017 ($ MILLIONS) 40TABLE 22 OCEANIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BYCOUNTRY, THROUGH 2017 ($ MILLIONS) 41TABLE 23 SOUTHEAST ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYSBY COUNTRY, THROUGH 2017 ($ MILLIONS) 41THE AMERICAS' DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 42TABLE 24 NORTH AMERICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYSBY COUNTRY, THROUGH 2017 ($ MILLIONS) 42TABLE 25 CENTRAL AND SOUTH AMERICAN DEMAND FOR INFECTIOUS DISEASEIMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 43AFRICA DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 43TABLE 26 NORTH AFRICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BYCOUNTRY, THROUGH 2017 ($ MILLIONS) 44TABLE 27 SUBSARAHAN AFRICAN DEMAND FOR INFECTIOUS DISEASEIMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 45MIDDLE EASTERN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 46TABLE 28 MIDDLE EASTERN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYSBY COUNTRY, THROUGH 2017 ($ MILLIONS) 46

CHAPTER 7 COMPANY PROFILES 49

TABLE 29 RANKING OF LEADING IMMUNOASSAY TECHNOLOGY MANUFACTURERS 49ABBOTT DIAGNOSTICS 49ACON LABORATORIES INC. 50AMAR IMMUNODIAGNOSTICS 50BAYER AG 51BECKMAN COULTER INC. 51HISTORY OF BECKMAN COULTER MANUAL IMMUNOASSAYS 51IMMUNOTECH 52DIAGNOSTIC SYSTEMS LABORATORIES (DSL) 52BECKMAN COULTER MANUAL IMMUNOASSAYS TODAY 52BECTON DICKENSON 53BEIJING WANGER BIOTECHNOLOGY CO. LTD. 53BHAT BIO-TECH INDIA PRIVATE LTD. 54BIOO SCIENTIFIC CORP. 54BIOVENDOR, LLC 54RESEARCH & DIAGNOSTIC PRODUCTS DIVISION 55LABORATORY MEDICINE DIVISION 55CLINICAL PRODUCTS DIVISION 55PROFESSIONAL CONSULTATION SERVICES 56BIOMERIEUX SA 56CANDOR BIOSCIENCE GMBH 56CAYMAN CHEMICAL CO. 57DIAMOND DIAGNOSTICS INC. 58DIASOURCE IMMUNOASSAYS S.A. 58IBL INTERNATIONAL GMBH 59IMMUNOCHEMISTRY TECHNOLOGIES LLC 60HISTORY 60PRODUCTS, SERVICES, AND RESEARCH 60IMMUNOSHOP INDIA PVT LTD. 61INSTITUTE OF ISOTOPES CO. LTD 61INSTRUMENTATION LABORATORY CO. 62NOVARTIS VACCINES & DIAGNOSTICS INC. 62JEI DANIEL BIOTECH CORP. 63LABOR DIAGNOSTIKA NORD GMBH & CO. KG 63MICROPOINT BIOSCIENCE INC. 64ORTHO CLINICAL DIAGNOSTICS 65PANTEX 65PROMEGA CORP. 65QQLAB LLC 66QUIDEL CORP. 66RADIOMETER GMBH 68ROCHE DIAGNOSTICS CORP. 69SIEMENS HEALTHCARE 69SYSMEX 69TRINITY BIOTECH PLC 70WEIFANG 3V BIOENGINEERING GROUP CO. LTD. 71WEIFANG KANGHUA BIOTECH CO. LTD. 71XIAMEN BOSON BIOTECH CO. LTD. 72ZHEJIANG ZHUJI BETAI BIOTECHNOLOGY CO. LTD. 73

CHAPTER 8 PATENT ANALYSIS 75

INTRODUCTION 75GLOBAL PATENT TRENDS 75TABLE 30 GLOBAL PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 75TABLE 31 GLOBAL PATENT SHARES BY ASSIGNEE 76U.S. PATENT TRENDS 80TABLE 32 U.S. PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OFPATENTS/%) 80TABLE 33 U.S. PATENT SHARES BY TECHNOLOGY, 2000-2012 81U.S. PATENT SHARES BY ASSIGNEE 81TABLE 34 U .S. PATENT SHARES BY ASSIGNEE 2000-2012 81SAMPLE ABSTRACTS OF U.S. PATENT ABSTRACTS 82AUTOANTIBODY-ENHANCED IMMUNOASSAYS AND KITS 82FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIALTOXIN ACTIVITY 82CHEMILUMINESCENT COMPOSITIONS FOR USE IN DETECTION OF MULTIPLEANALYTES 83U.S. REGISTERED PATENTS 83TABLE 35 SAMPLE OF U.S. IMMUNOASSAY PATENTS, 2000-2012 84EUROPEAN PATENT TRENDS 84TABLE 36 EUROPEAN PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OFPATENTS/%) 84TABLE 37 EUROPEAN PATENT SHARES BY TECHNOLOGY, 2000-2012 85EUROPEAN PATENT SHARES BY PATENT HOLDER 85TABLE 38 EUROPEAN PATENT SHARES BY APPLICATION, 2000-2012 86SAMPLE ABSTRACTS OF EUROPEAN PATENT ABSTRACTS 87IMMUNOASSAY PRODUCT AND PROCESS 87ENZYME IMMUNOASSAY MEMBRANE STRIP WITH CRITICAL VALUE LINEAND INTERPRETATION METHOD THEREOF 88FLUORESCENCE IMMUNOASSAY METHOD OF USING ZINC OXIDE QUANTUMDOTS TO MARK ANTIBODY 88EUROPEAN REGISTERED PATENTS 88TABLE 39 SAMPLE OF EUROPEAN IMMUNOASSAY PATENTS, 2000-2012 89JAPANESE PATENT TRENDS 89TABLE 40 JAPANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 90TABLE 41 JAPANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OFPATENTS/%) 90JAPANESE PATENT SHARES BY ASSIGNEE 90TABLE 42 JAPANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OFPATENTS/%) 90SAMPLE ABSTRACTS OF JAPANESE PATENT ABSTRACTS 91ENZYME IMMUNOASSAY USING ENZYME LABELED ANTIBODY 91FLUORESCENCE IMMUNOASSAY 92FLUORESCENT POLYMER MICROPARTICLE, ITS PRODUCTION, ANDREAGENT AND METHOD FOR FLUORO IMMUNOASSAY UTILIZING THE SAME 92JAPANESE PATENT REGISTERED PATENTS 93TABLE 43 SAMPLE OF JAPANESE IMMUNOASSAY PATENTS, 2000-2012 93CHINESE PATENT TRENDS 93TABLE 44 CHINESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 94TABLE 45 CHINESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OFPATENTS/%) 94CHINESE PATENT SHARES BY HOLDER 95TABLE 46 CHINESE PATENT SHARES BY PATENT HOLDER, 2000-2012 (NO. OFPATENTS/%) 95SAMPLE ABSTRACTS OF CHINESE PATENT ABSTRACTS 96IMMUNOASSAY AND DIAGNOSTIC REAGENT FOR MALARIA 96ENZYME IMMUNOASSAY KIT FOR COXSACKIE VIRUS B ANTIGEN AND ITSPREPARING PROCESS 97VISUAL FLUORESCENCE IMMUNOASSAY METHOD FOR DETERMININGBIOLOGICAL ACTIVE SUBSTANCE 97CHINESE PATENTS 97TABLE 47 SAMPLE OF CHINESE IMMUNOASSAY PATENTS, 2000-2012 98TAIWANESE PATENT TRENDS 98TABLE 48 TAIWANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OFPATENTS/%) 99TABLE 49 TAIWANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OFPATENTS/%) 99TABLE 50 TAIWANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OFPATENTS/%) 100SAMPLE ABSTRACTS OF TAIWAN PATENTS 100IMMUNOASSAY METHOD FOR DETERMINING GLYCOSYLATED PROTEIN ANDTEST LIQUID THEREOF 100CARRIER-ENZYME-PROTEIN COMPLEX AND IMMUNOASSAY KITCOMPRISING THE SAME 100TAIWANESE REGISTERED PATENTS 101TABLE 51 SAMPLE OF TAIWANESE IMMUNOASSAY PATENTS, 2000-2012 101SOUTH KOREA PATENT TRENDS 101TABLE 52 SOUTH KOREAN PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO.OF PATENTS/%) 102TABLE 53 SOUTH KOREAN PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OFPATENTS/%) 102TABLE 54 SOUTH KOREAN PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OFPATENTS/%) 103SAMPLE ABSTRACTS OF SOUTH KOREAN PATENTS 104IMMUNOASSAY METHOD USING MEASUREMENT VALUE LOWERINGINHIBITOR FOR IMMUNOASSAY METHOD 104METHOD OF IMMUNOASSAY FOR THE DETECTION OF TEICOPLANIN 104IMMUNOASSAY DEVICE FOR ASSAYING WHOLE BLOOD ANDIMMUNOASSAY METHOD USING THE SAME 105SOUTH KOREAN REGISTERED PATENTS 105TABLE 55 SAMPLE OF SOUTH KOREAN IMMUNOASSAY PATENTS,2000-2012 106

LIST OF TABLES SUMMARY TABLE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, THROUGH

2017 ($ MILLIONS) 7

TABLE 1 ADVANTAGES OF ENZYME IMMUNOASSAY 10

TABLE 2 LIMITATIONS OF ENZYME IMMUNOASSAY 11

TABLE 3 ADVANTAGES OF FLUORESCENT IMMUNOASSAY 11

TABLE 4 LIMITATIONS OF FLUORESCENT IMMUNOASSAY 12

TABLE 5 ADVANTAGES OF RADIOISOTOPES 15

TABLE 6 LIMITATIONS OF RADIOISOTOPES 15

TABLE 7 GLOBAL MEDICAL PRODUCTS MARKET, 2012-2017 ($ BILLIONS) 19

TABLE 8 WESTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRY

THROUGH 2017 ($ MILLIONS) 22

TABLE 9 EASTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,

THROUGH 2017 ($ MILLIONS) 25

TABLE 10 ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($

MILLIONS) 26

TABLE 11 OCEANIA DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($

MILLIONS) 27

TABLE 12 SOUTHEAST ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,

THROUGH 2017 ($ MILLIONS) 28

TABLE 13 NORTH AMERICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,

THROUGH 2017 ($ MILLIONS) 29

TABLE 14 CENTRAL AND SOUTH AMERICAN DEMAND FOR IMMUNOASSAYS BY

COUNTRY, THROUGH 2017 ($ MILLIONS) 30

TABLE 15 NORTH AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH

2017 ($ MILLIONS) 31

TABLE 16 SUB-SAHARAN AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,

THROUGH 2017 ($ MILLIONS) 32

TABLE 17 MIDDLE EASTERN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH

2017 ($ MILLIONS) 34

TABLE 18 GLOBAL DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY REGION,

THROUGH 2017 ($ MILLIONS) 37

TABLE 19 WESTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS

BY COUNTRY, THROUGH 2017 ($ MILLIONS) 38

TABLE 20 EASTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS

BY COUNTRY, THROUGH 2017 ($ MILLIONS) 39

TABLE 21 ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY COUNTRY,

THROUGH 2017 ($ MILLIONS) 40

TABLE 22 OCEANIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY

COUNTRY, THROUGH 2017 ($ MILLIONS) 41

TABLE 23 SOUTHEAST ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS

BY COUNTRY, THROUGH 2017 ($ MILLIONS) 41

TABLE 24 NORTH AMERICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY

COUNTRY, THROUGH 2017 ($ MILLIONS) 42

TABLE 25 CENTRAL AND SOUTH AMERICAN DEMAND FOR INFECTIOUS DISEASE

IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 43

TABLE 26 NORTH AFRICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY

COUNTRY, THROUGH 2017 ($ MILLIONS) 44

TABLE 27 SUBSARAHAN AFRICAN DEMAND FOR INFECTIOUS DISEASE

IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 45

TABLE 28 MIDDLE EASTERN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY

COUNTRY, THROUGH 2017 ($ MILLIONS) 46

TABLE 29 RANKING OF LEADING IMMUNOASSAY TECHNOLOGY MANUFACTURERS 49

TABLE 30 GLOBAL PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF

PATENTS/%) 75

TABLE 31 GLOBAL PATENT SHARES BY ASSIGNEE 76

TABLE 32 U.S. PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OF

PATENTS/%) 80

TABLE 33 U.S. PATENT SHARES BY TECHNOLOGY, 2000-2012 81

TABLE 34 U .S. PATENT SHARES BY ASSIGNEE 2000-2012 81

TABLE 35 SAMPLE OF U.S. IMMUNOASSAY PATENTS, 2000-2012 84

TABLE 36 EUROPEAN PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OF

PATENTS/%) 84

TABLE 37 EUROPEAN PATENT SHARES BY TECHNOLOGY, 2000-2012 85

TABLE 38 EUROPEAN PATENT SHARES BY APPLICATION, 2000-2012 86

TABLE 39 SAMPLE OF EUROPEAN IMMUNOASSAY PATENTS, 2000-2012 89

TABLE 40 JAPANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF

PATENTS/%) 90

TABLE 41 JAPANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF

PATENTS/%) 90

TABLE 42 JAPANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF PATENTS/%) 90

TABLE 43 SAMPLE OF JAPANESE IMMUNOASSAY PATENTS, 2000-2012 93

TABLE 44 CHINESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF

PATENTS/%) 94

TABLE 45 CHINESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF

PATENTS/%) 94

TABLE 46 CHINESE PATENT SHARES BY PATENT HOLDER, 2000-2012 (NO. OF

PATENTS/%) 95

TABLE 47 SAMPLE OF CHINESE IMMUNOASSAY PATENTS, 2000-2012 98

TABLE 48 TAIWANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF

PATENTS/%) 99

TABLE 49 TAIWANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF

PATENTS/%) 99

TABLE 50 TAIWANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF

PATENTS/%) 100

TABLE 51 SAMPLE OF TAIWANESE IMMUNOASSAY PATENTS, 2000-2012 101

TABLE 52 SOUTH KOREAN PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO.

OF PATENTS/%) 102

TABLE 53 SOUTH KOREAN PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF

PATENTS/%) 102

TABLE 54 SOUTH KOREAN PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF

PATENTS/%) 103

TABLE 55 SAMPLE OF SOUTH KOREAN IMMUNOASSAY PATENTS,2000-2012 106

LIST OF FIGURES SUMMARY FIGURE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, 2011-2017 ($

MILLIONS) 7

To order this report:In_Vitro_Diagnostic Industry: Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays

Contact Clare: clare@reportlinker.com

US:(339) 368 6001

Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
2. AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance
3. Patient Safety Technologies Reports First Quarter 2013 Results
4. Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
5. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
6. Blue Belt Technologies kündigt Gründung eines wissenschaftlichen Beirats für Hüfteingriffe zur Bestimmung neuer Anwendungsgebiete von NavioPFS bei femoro-acetabulärem Impingement an
7. Blue Belt Technologies maakt vorming van Wetenschappelijke Heup Adviesraad bekend voor ontwikkeling van volgende NavioPFS-toepassing voor femoroacetabulair impingement
8. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
9. Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
10. Update to Shareholders on Dividend Payment: Medisafe 1 Technologies Corporation Files Corporate Action Form with FINRA for the Dividend Distribution to its Shareholders
11. Flexpoint Announces Universal Settlement Involving the Medical Bed and Related Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016  This month,s issue of the Journal ... an in-depth look at various causes and consequences associated with rising ... spending, which has generated significant public outrage and calls ... Laura E. Happe , PharmD, MPH. --> ... MPH. --> In 2014 prescription drug spending ...
(Date:2/12/2016)... Inc. (NYSE: DPLO ) is pleased to announce the promotion of Paul Urick ... 23, 2016. To learn more about our ... ... ... In his redefined ...
(Date:2/12/2016)... 2016 /PRNewswire/ - Demers Ambulances announces its first delivery in the ... Okaloosa County Emergency Medical Services (EMS) consisting of ... LT2 van. Quality Emergency Vehicles in Lecanto, FL ... sale.  This is the latest in Demers, ongoing expansion of ... at Demers. --> Benoit LaFortune , Executive Vice ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan ... The purpose of these scholarships is to encourage applicants to pursue a degree in ... within these two parishes. , “We have available jobs in St. Landry and ...
(Date:2/12/2016)... Boca Raton, FL (PRWEB) , ... February 12, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted over 250 members of South Florida’s philanthropic community at ...
(Date:2/12/2016)... VA (PRWEB) , ... February 12, 2016 , ... ... Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... in the life cycle of pharmaceutical products, garnering increased attention from all stakeholders ...
(Date:2/12/2016)... ... 2016 , ... As a former television executive, owner Tal Rabinowitz knows how ... to decompress, Rabinowitz found herself drawn to a casual meditation class while working at ... life, implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a technology and information ... ISE Southeast Awards 2016. Finalists and winners of the ISE® Awards for both ... and Awards Gala on March 15, 2016 at the Westin Peachtree Plaza, Atlanta. ...
Breaking Medicine News(10 mins):